Covalon Technologies Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Covalon Technologies.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 26.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Subdued Growth No Barrier To Covalon Technologies Ltd. (CVE:COV) With Shares Advancing 29%
Nov 17
Covalon Technologies Ltd.'s (CVE:COV) 25% Share Price Surge Not Quite Adding Up
Aug 18We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth
Aug 10Optimistic Investors Push Covalon Technologies Ltd. (CVE:COV) Shares Up 83% But Growth Is Lacking
Jun 16Covalon Technologies (CVE:COV) Is In A Good Position To Deliver On Growth Plans
May 01Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Feb 17Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price
Dec 22We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth
Sep 02We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully
May 26Is Covalon Technologies (CVE:COV) Using Too Much Debt?
Apr 29Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt
Dec 29In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Covalon Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 29 | -1 | 1 | 1 | N/A |
| 3/31/2024 | 26 | -3 | -3 | -2 | N/A |
| 12/31/2023 | 25 | -5 | -4 | -3 | N/A |
| 9/30/2023 | 27 | -4 | -5 | -3 | N/A |
| 6/30/2023 | 25 | -6 | -6 | -5 | N/A |
| 3/31/2023 | 23 | -7 | -9 | -8 | N/A |
| 12/31/2022 | 19 | -9 | -10 | -8 | N/A |
| 9/30/2022 | 18 | -9 | -9 | -8 | N/A |
| 6/30/2022 | 19 | -4 | -8 | -8 | N/A |
| 3/31/2022 | 21 | -2 | -4 | -3 | N/A |
| 12/31/2021 | 22 | 0 | 0 | 0 | N/A |
| 9/30/2021 | 20 | 0 | 0 | 0 | N/A |
| 6/30/2021 | 7 | -4 | 1 | 1 | N/A |
| 3/31/2021 | 7 | -4 | 1 | 1 | N/A |
| 12/31/2020 | 8 | -8 | 0 | 0 | N/A |
| 9/30/2020 | 14 | -8 | -4 | -4 | N/A |
| 6/30/2020 | 26 | -8 | -3 | -3 | N/A |
| 3/31/2020 | 27 | -12 | -4 | -4 | N/A |
| 12/31/2019 | 35 | -8 | -5 | -4 | N/A |
| 9/30/2019 | 34 | -9 | -4 | -3 | N/A |
| 6/30/2019 | 34 | -6 | -3 | -2 | N/A |
| 3/31/2019 | 35 | -1 | -3 | -2 | N/A |
| 12/31/2018 | 28 | -1 | -5 | -4 | N/A |
| 9/30/2018 | 27 | 2 | -1 | -1 | N/A |
| 6/30/2018 | 30 | 3 | -1 | -1 | N/A |
| 3/31/2018 | 28 | 1 | N/A | -1 | N/A |
| 12/31/2017 | 28 | 2 | N/A | 0 | N/A |
| 9/30/2017 | 27 | 2 | N/A | 0 | N/A |
| 6/30/2017 | 18 | -1 | N/A | -2 | N/A |
| 3/31/2017 | 15 | -1 | N/A | -1 | N/A |
| 12/31/2016 | 10 | -3 | N/A | -1 | N/A |
| 9/30/2016 | 7 | -3 | N/A | -1 | N/A |
| 6/30/2016 | 8 | -2 | N/A | -3 | N/A |
| 3/31/2016 | 7 | -2 | N/A | -3 | N/A |
| 12/31/2015 | 9 | 0 | N/A | -3 | N/A |
| 9/30/2015 | 8 | -1 | N/A | -2 | N/A |
| 6/30/2015 | 7 | -1 | N/A | -1 | N/A |
| 3/31/2015 | 6 | -1 | N/A | -1 | N/A |
| 12/31/2014 | 6 | -1 | N/A | -1 | N/A |
| 9/30/2014 | 9 | 2 | N/A | 3 | N/A |
| 6/30/2014 | 9 | 3 | N/A | 3 | N/A |
| 3/31/2014 | 10 | 4 | N/A | 3 | N/A |
| 12/31/2013 | 8 | 3 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if COV's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if COV's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if COV's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if COV's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if COV's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if COV's Return on Equity is forecast to be high in 3 years time